ANTIMICROBIAL TECHNOLOGIES & DRUG DELIVERY PLATFORMS
With
Associate Professor Aaron Elbourne, RMIT University, Melbourne, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | January 2026
Dr Aaron Elbourne is an ARC DECRA Fellow, Jack Brockhoff ECR Fellow, and Associate Professor within the School of Science at STEM Hub. A leader in nanomaterials, soft matter science, and interface research, Aaron’s work addresses critical challenges in health and the environment.
Since becoming an independent researcher, Aaron has held continuous funding from prestigious funders, including the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). His research is characterised by its interdisciplinary approach, combining chemistry, materials science, and engineering. His pioneering contributions to colloid therapeutics and soft matter science have driven advancements in diagnostic tools, antimicrobial technologies, and therapeutic delivery systems. His expertise in studying nanomaterial interactions with synthetic and biological membranes has been instrumental in translating scientific discoveries into impactful applications.
Aaron is a dedicated mentor to early-career researchers (ECRs) and students, having supervised and trained numerous postgraduate and doctoral candidates. He has played a key role in securing funding for student training initiatives, including joint PhD scholarships and National Industry PhD programs, which emphasise collaboration between academia and industry.
With a strong focus on translational research, Aaron’s work bridges the gap between fundamental science and practical applications. His leadership in creating innovative technologies, fostering academic-industry partnerships, and empowering future researchers underscores his commitment to advancing science and creating a meaningful impact.
Source: Supplied
https://orcid.org/0000-0002-8562-7325
-
Clinical Research in Emergency Medicine
Professor Daniel Fatovich is a senior emergency physician and clinical researcher at Royal Perth Hospital Emergency Department (ED), with over 30 years’ experience in the design and conduct of clinical research in Emergency Medicine. He is also Head of the Centre for Clinical Research in Emergency Medicine (CCREM) within the Harry Perkins Institute of Medical Research.
-
Tyrosine Kinases in cancer recurrence
Dr Yu Yu leads the Oncology and Gynaecology Research Program at Curtin Medical Research Institute . Dr Yu is also a senior research fellow at Curtin Medical School.
Dr Yu Yu’s laboratory is working on better ways to treat cancers, particularly ovarian cancers which are resistant to conventional chemotherapy. The aims are for better informed treatment choice and reducing unnecessary exposure to ineffective chemotherapy and its potential adverse effects.
-
Nutraceutical and pharmacological intervention in neurological disorders
Dr Virginie Lam is a neuroscientist and cerebrovascular biologist with over 15 years of research experience, including more than seven years post-PhD. She co-leads the Neurovascular and Metabolic Diseases Laboratory at the Curtin Medical Research Institute and holds an affiliate appointment at the Perron Institute for Neurological and Translational Science. Her research focuses on the interface between neurovascular health, cognitive function, and therapeutic translation in neurodegenerative disorders.
